MUTAMYCIN (Accord BioPharma Inc.)
Welcome to the PulseAid listing for the MUTAMYCIN drug offered from Accord BioPharma Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Accord BioPharma Inc. |
NON-PROPRIETARY NAME: | Mitomycin |
SUBSTANCE NAME: | MITOMYCIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-07-25 |
END MARKETING DATE: | 0000-00-00 |
MUTAMYCIN HUMAN PRESCRIPTION DRUG Details:
Item Description | MUTAMYCIN from Accord BioPharma Inc. |
LABELER NAME: | Accord BioPharma Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/10mL) |
START MARKETING DATE: | 2017-07-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69448-001_55ab68d0-c46a-2f41-e054-00144ff88e88 |
PRODUCT NDC: | 69448-001 |
APPLICATION NUMBER: | ANDA064144 |
Other MITOMYCIN Pharmaceutical Manufacturers / Labelers: